Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAT | P00750 | 1/20 | 0.34 |
| ▸ | FASN | P49327 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | F2R | P25116 | 1/20 | 0.32 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.30 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3970526 | 0.87 | CNR1 (0.34) | PLATCNR1F2RTMEM97 | |
| SCHEMBL3964413 | 0.87 | HTT (0.36) | PLATFASNCNR1F2RTMEM97 | |
| SCHEMBL3974813 | 0.85 | HDAC4 (0.33) | S1PR1 | |
| SCHEMBL2954870 | 0.84 | F2R (0.46) | CNR1F2RTMEM97KCNH2 | |
| SCHEMBL3802613 | 0.83 | CNR1 (0.34) | PLATCNR1F2RTMEM97 | |
| SCHEMBL641918 | 0.83 | F2R (0.43) | FASNCNR1F2RTMEM97 | |
| SCHEMBL641145 | 0.82 | F2R (0.44) | FASNCNR1F2RTMEM97CACNA1G | |
| SCHEMBL3963593 | 0.78 | LMNA (0.37) | CNR1F2RTMEM97KCNH2 | |
| SCHEMBL3969107 | 0.77 | TACR1 (0.35) | CNR1F2RTMEM97KCNH2 | |
| SCHEMBL15261923 | 0.77 | F2R (0.44) | CNR1F2RTMEM97 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090306139-A1 | HETEROARYL-SUBSTITUTED PIPERIDINES | BAYER HEALTHCARE AG (DE) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306139-A1 | HETEROARYL-SUBSTITUTED PIPERIDINES | VHL, PIGO, PLIN3 | PLAT 1807/4885FASN 1402/4885CNR1 454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.